AIML Innovations Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- J. Paul Duffy
- Full Time Employees
- 3
- Sector
- Technology services
- Industry
- Information technology services
- Address
- Pacific Centre Victoria BC Canada V7Y 1B3
- IPO Date
- Feb 13, 2020
- Website
- aiml.health
- Similar Companies
- Business
- AI/ML Innovations Inc. AI/ML Innovations Inc. (AIML.CN) develops and commercializes artificial intelligence and machine learning technologies for digital healthcare, focusing on non-invasive biometric signal processing and predictive health analytics. The company offers MaxYield, a device-agnostic AI-powered neural network for ECG signal processing that extracts clean signals from noisy recordings with precise PQRST labeling; AI PrecisionPulse Neural Network for analyzing biometric data to detect cardiovascular anomalies and provide personalized health recommendations; and Health Gauge solutions for capturing vital signs including blood pressure, heart rate, and pulse wave velocity, alongside licenses and consulting services for health and wearable technologies. Founded in 1983 and headquartered in Victoria, Canada, with operations primarily in Canada, AI/ML Innovations Inc. functions as a holding company with subsidiaries and investments such as 70%-owned Health Gauge and AI Rx Inc., and partnerships including Tech2Heal. Recent developments include the establishment of a Medical Advisory Board in May 2025 chaired by Peter Kendall, President and Chief Commercialization Officer, to advance AI-powered ECG innovations; completion of the acquisition of technology assets from Naiad Lab Inc. via issuance of 6.7 million shares; closure of the acquisition of Quantum Sciences Ltd. in December 2024 to expand cardio AI capabilities; a proposed private placement announced in September 2025 to fund AI and machine learning initiatives in digital health; key executive appointments such as Dr. Alan Rabinowitz as Chief Medical Officer, Andrea L. Ruth as Head of Quality, Clinical and Regulatory Affairs, and additions to the board of directors; and a name change from AIML Resources Inc. in November 2020.
Company News
AI/ML Innovations Announces Completion of Share Issuance
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield(TM) Clinical Pilots
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
AI/ML Innovations Inc. Closes Final Tranche of Private Placement
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
AI/ML Innovations Inc. Closes First Tranche of Private Placement
AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield(TM) Pilot
AI/ML Innovations Inc. Announces Proposed Private Placement
AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
AI/ML Innovations Announces Completion of Share Issuance
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
AI/ML Innovations Announces Completion of Share Issuance
AI/ML Innovations Announces Completion of Share Issuance
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000